The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...